TickerFacts.

Inovio Pharmaceuticals, Inc. (INO): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-12, first reflected in a filing dated 2024-03-06. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

46.89M
Year ended 2025-12-31
+33.1%
3-year compound annual growth
155.13M2012-12-31: 34.13M2013-12-31: 46.09M2014-12-31: 59.41M2015-12-31: 68.37M2016-12-31: 73.21M2017-12-31: 81.92M2018-12-31: 92.54M2019-12-31: 98.72M2020-12-31: 155.13M2021-12-31: 17.40M2022-12-31: 19.89M2023-12-31: 22.17M2024-12-31: 27.16M2025-12-31: 46.89M46.89M
2012-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3146.89M+72.6%2026-03-12, From 2025-01-01
2024-12-3127.16M+22.5%2026-03-12, From 2024-01-01
2023-12-3122.17M+11.5%2025-03-18, From 2023-01-01
2022-12-3119.89M+14.3%2024-03-06, From 2022-01-01
2021-12-3117.40Mn/c2024-03-06, From 2021-01-01
2020-12-31155.13Mn/c2023-03-01, From 2020-01-01
2019-12-3198.72M+6.7%2022-03-01, From 2019-01-01
2018-12-3192.54M+13.0%2020-03-12, From 2018-01-01
2017-12-3181.92M+11.9%2020-03-12, From 2017-01-01
2016-12-3173.21M+7.1%2019-03-12, From 2016-01-01
2015-12-3168.37M+15.1%2018-03-14, From 2015-01-01
2014-12-3159.41M+28.9%2017-03-15, From 2014-01-01
2013-12-3146.09M+35.0%2016-03-14, From 2013-01-01
2012-12-3134.13Mn/a2015-03-16, From 2012-01-01